<DOC>
	<DOCNO>NCT02087566</DOCNO>
	<brief_summary>Renal failure patient treat linezolid ( LZD ) proven suspect infection multiresistant Gram-positive cocci . The aim study determine dose adjustment LZD need function renal impairment , especially significant component LZD eliminate unchanged urine .</brief_summary>
	<brief_title>Linezolid Pharmacokinetics In Patients With Impaired Renal Function ( PPT6 )</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Healthy subject normal renal function ( CLcr ˃80 ml/min ) ; Patients acute renal failure ( RF ) ( 30˂CLcr˂80 ml/mine ) Patients long term HD ideal body weight &gt; 60 kg body mass index 20 26 kg/m2 Passed screen parameter Free drug exposure know interfere pharmacokinetics assay linezolid least 10 day prior study Able communicate effectively study personnel , literate , able give consent . Had history clinically significant organ dysfunction renal disease disease associate renal disease ( case acute RF ESRD patient ) Had physical examination laboratory test result outside inclusion ; sit systolic BP ( SBP ) &gt; 140 &lt; 100 mmHg , diastolic BP ( DBP ) &gt; 90 &lt; 60mm Hg ( case healthy volunteer acute RF patient ) , pulse rate &gt; 95 &lt; 50 beats/min screening ; history orthostatic hypotension ; history serious intolerance , allergy sensitivity linezolid ; history blood dyscrasia ; history alcohol , smoking , drug abuse ; donation blood 8 week prior study plan donate blood within 8 week complete study ; unable tolerate vein puncture multiple blood sampling ; surgical/medical condition might alter absorption , distribution , metabolism , excretion linezolid ; ca n't follow instruction , accord investigator 's opinion .</criteria>
	<gender>Male</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Linezolid</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Haemodialysis</keyword>
	<keyword>Dosing adjustment</keyword>
	<keyword>Eligible subject classify three group depend 24-h urinary creatinine clearance ( CLcr ) value HD status .</keyword>
	<keyword>Group 1 , include 6 healthy subject normal renal function ( CLcr ˃80 ml/min ) ;</keyword>
	<keyword>Group 2 , include 6 patient acute renal failure ( RF ) ( 30˂CLcr˂80 ml/mine ) ;</keyword>
	<keyword>Group 3 , include 6 patient long term haemodialysis ( minimum period dialysis 40 month maximum period 130 month )</keyword>
</DOC>